John W. Rose
Rating: 5.0 of 5
( out of 110 reviews )

John W. Rose, MD

Languages spoken: English

Clinical Locations

Primary Location

Imaging & Neurosciences Center

729 Arapeen Dr
Salt Lake City , UT 84108
801-585-7575
Get Directions

  • John Rose, MD, is Neuroimmunology & Autoimmune Neurology Division Chief and Professor of Neurology at the University of Utah, and is chief of neurology at the Salt Lake City Veterans Administration Hospital. Dr. Rose and his colleagues investigate diverse aspects of multiple sclerosis (MS), including the immunopathology of MS and related models, the development of new treatments for MS, early disease detection with advanced magnetic resonance imaging, and the detection of susceptibility genes for MS.

    Dr. Rose's focus is on multiple sclerosis clinical care and research. His clinic is a Partner in Care with the National Multiple Sclerosis Society and designated a Comprehensive Care Center. There are ongoing clinical investigations of neurogenic pain, OCT, and immunotherapies. One special area of research is Pediatric Multiple Sclerosis, including clinical and translational investigations. Another important area is development of Magnetic Resonance Imaging for detection of demyelination and remyelination.

    Dr. Rose sees patients at University of Utah, a Partner in Care with the National Multiple Sclerosis Society and designated a Comprehensive Care Center.

    His favorite sport is lacrosse.

    Specialties

    Board Certification

    American Board of Psychiatry & Neurology (Neurology)
    National Board of Medical Examiners

    Patient Rating

    Rating: 5.0 out of 5
    5.0 /5
    ( out of 110 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    CLINICAL NEUROSCIENCES CENTER
    Rating: 5 out of 5

    Dr. Rose has always been such a Great Dr. for me... couldn't imagine going thru my MS journey without him.

    CLINICAL NEUROSCIENCES CENTER
    Rating: 5 out of 5

    He goes all of the above in a professional, competent and caring manner

    CLINICAL NEUROSCIENCES CENTER
    Rating: 5 out of 5

    Ive been his patient for 16 years and and still feel very blessed to be able to keep seeing him!

    CLINICAL NEUROSCIENCES CENTER
    Rating: 5 out of 5

    Very best Doctor!

    CLINICAL NEUROSCIENCES CENTER
    Rating: 5 out of 5

    Dr Rose is very thorough and professional. He makes certain that my questions are answered and my needs are met.

    CLINICAL NEUROSCIENCES CENTER
    Rating: 5 out of 5

    Fantastic doc that said cares

    CLINICAL NEUROSCIENCES CENTER
    Rating: 5 out of 5

    Dr. Rose is very knowledgable and responds to my requests.

    CLINICAL NEUROSCIENCES CENTER
    Rating: 5 out of 5

    I trust him completely with my treatment. I wouldn't want anyone else to my specialist for MS

    CLINICAL NEUROSCIENCES CENTER
    Rating: 5 out of 5

    He's a fantastic doctor who helps me a lot.

  • John Rose, MD, is Neuroimmunology & Autoimmune Neurology Division Chief and Professor of Neurology at the University of Utah, and is chief of neurology at the Salt Lake City Veterans Administration Hospital. Dr. Rose and his colleagues investigate diverse aspects of multiple sclerosis (MS), including the immunopathology of MS and related models, the development of new treatments for MS, early disease detection with advanced magnetic resonance imaging, and the detection of susceptibility genes for MS.

    Dr. Rose's focus is on multiple sclerosis clinical care and research. His clinic is a Partner in Care with the National Multiple Sclerosis Society and designated a Comprehensive Care Center. There are ongoing clinical investigations of neurogenic pain, OCT, and immunotherapies. One special area of research is Pediatric Multiple Sclerosis, including clinical and translational investigations. Another important area is development of Magnetic Resonance Imaging for detection of demyelination and remyelination.

    Dr. Rose sees patients at University of Utah, a Partner in Care with the National Multiple Sclerosis Society and designated a Comprehensive Care Center.

    His favorite sport is lacrosse.

    Board Certification and Academic Information

    Academic Departments Neurology -Professor
    Board Certification
    American Board of Psychiatry & Neurology (Neurology)
    National Board of Medical Examiners

    Education history

    Undergraduate Biology (September 1969 to June 1971) - Johns Hopkins University B.A.
    Professional Medical Medicine (September 1971 to June 1975) - University of Maryland M.D.
    Internship Medicine (July 1975 to June 1976) - Maryland General Hospital Intern
    Residency Neurology (July 1976 to June 1979) - University of Maryland Resident
    Chief Resident Neurology (July 1978 to June 1978) - University of Maryland Chief Resident
    Fellowship Neurology (July 1979 to June 1980) - National Institute of Health Fellow
    Fellowship Neuroimmunology (July 1981 to June 1985) - National Institute of Health Fellow

    Selected Publications

    Journal Article

    1. Kim TH, Zollinger L, Shi XF, Kim SE, Rose J, Patel AA, Jeong E (2010). Quantification of diffusivities of the human cervical spinal cord using a 2D single-shot interleaved multisection inner volume diffusion-weighted echo-planar imaging technique. AJNR. American journal of neuroradiology, 31(4), 682-7. (Read full publication)
    2. Martins TB, Rose JW, Jaskowski TD, Wilson AR, Husebye D, Seraj HS, Hill HR (2011). Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay. American journal of clinical pathology, 136(5), 696-704.
    3. Sato F, Martinez NE, Shahid M, Rose JW, Carlson NG, Tsunoda (2013). Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. The American journal of pathology, 183(5), 1390-1396. (Read full publication)
    4. Kim T, Zollinger L, Shu X, Rose JW, Jeong (2009). Diffusion tensor imaging of ex vivo cervical spinal cord specimens: the immediate and long term effects of fixation on diffusivity. The Anatomical record, 292, 234-41.
    5. Krysko KM, Graves JS, Rensel M, Weinstock-Guttman B, Rutatangwa A, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Goyal MS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waltz M, Casper TC, Waubant E, US Network of Pediatric MS Centers (2020). Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Annals of neurology, 88(1), 42-55. (Read full publication)
    6. Chitnis T, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Roalstad S, Rose J, Weiner HL, Casper TC, Rodriguez M, US Network of Paediatric Multiple Sclerosis Centers (2020). Improved relapse recovery in paediatric compared to adult multiple sclerosis. Brain, 143(9), 2733-2741. (Read full publication)
    7. Zollinger LV, Kim TH, Hill K, Jeong EK, Rose J (2011). Using diffusion tensor imaging and immunofluorescent assay to evaluate the pathology of multiple sclerosis. Journal of magnetic resonance imaging, 33(3), 557-64. (Read full publication)
    8. Seo HS, Kim SE, Rose JW, Hadley JR, Parker DL, Jeong E (2013). Diffusion tensor imaging of extraocular muscle using two-dimensional single-shot interleaved multiple inner volume imaging diffusion-weighted EPI at 3 tesla. Journal of magnetic resonance imaging, 38(5), 1162-1168.
    9. Thapa B, Sapkota N, Lee Y, Jeong K, Rose J, Shah LM, Bisson E, Jeong E (2019). Ultra-high-b radial diffusion-weighted imaging (UHb-rDWI) of human cervical spinal cord. Journal of magnetic resonance imaging, 49(1), 204-211. (Read full publication)
    10. Langer HF, Choi EY, Zhou H, Schleicher R, Chung KJ, Tang Z, Gobel K, Bdeir K, Chatzigeorgiou A, Wong C, Bhatia S. Kruhlak MJ, Rose JW, Burns JB, Hill KE, Qu H, Zhang Y, Lehrmann E, Becker KG, Wang Y, Simon DI, Nieswandt B., Lambris JD, Li X, Meuth SG, Kubes P, Chavakis T (2012). Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circulation research, 110(9), 1202-10.
    11. Villani LA, Stulberg EL, Abbatemarco JR, Davidson CJ, Kadish R, Renner DR, Soldan MMP, Rose JW, Clardy SL, Greenlee J (2021). Biopsy-proven PML in an HIV-negative patient with discoid lupus: Failure to detect JC virus in CSF. Clinical neurology and neurosurgery, 209, 106843. (Read full publication)
    12. Brettschneider J, Jaskowski TD, Tumani H, Abdul S, Husebye D, Seraj H, Hill HR, Fire E, Spector L, Yarden J, Dotan N, Rose J (2009). Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases. Journal of neuroimmunology, 217(1-2), 95-101. (Read full publication)
    13. Waldman AT, Gorman MP, Rensel MR, Austin Te, Hertz DP, et a (2011). Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists. Journal of child neurology, 26(6), 675-82.
    14. Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, Graves J, Tillema JM, Benson L, Harris (2014). The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. Journal of child neurology, 09/30/2014, 1-7.
    15. Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, Graves J, Tillema JM, Benson L, Harris Y, US Network of Pediatric Multiple Sclerosis Centers (2015). The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. Journal of child neurology, 30(10), 1381-7. (Read full publication)
    16. Aaen G, Waltz M, Vargas W, Makhani N, Ness J, Harris Y, Casper TC, Benson L, Candee M, Chitnis T, Gorman M, Graves J, Greenberg B, Lotze T, Mar S, Tillema JM, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Belman A, Waubant E, Krupp (2019). Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis. Journal of child neurology, 34(3), 148-152. (Read full publication)
    17. Martins TB, Rose JW, Gardiner GL, Kusukawa N, Husebye D, Hill H (2013). Cell-based reporter gene assay for therapy-induced neutralizing antibodies to interferon-beta in multiple sclerosis. Journal of interferon research, 33(2), 52-7.
    18. Fjeldstad AS, McDaniel J, Witman MA, Ives SJ, Zhao J, Rose JW, Hannon J, Wray DW, Richardson R (2011). Vascular function and multiple sclerosis. Journal of neurology, 258(11), 2036-42. (Read full publication)
    19. Nourbakhsh B, Graves J, Casper TC, Lulu S, Waldman A, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos L, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2016). Dietary salt intake and time to relapse in paediatric multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 87(12), 1350-1353. (Read full publication)
    20. Azary S, Schreiner T, Graves J, Waldman A, Belman A, Guttman BW, Aaen G, Tillema JM, Mar S, Hart J, Ness J, Harris Y, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos LF, Lotze T, Carmichael SL, Roalstad S, Casper CT, Waubant (2018). Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 89(1), 28-33. (Read full publication)
    21. Wolinski JS, Sochat T, Weiss S, Ladkani D: PROMiSe Trial Study Group (J Rose site PI (2009). Glatiramer acetate treatment in PPMS: why males appear to respond favorably. Journal of the neurological sciences, 15, 286-928.
    22. Wolinsky J (2003). The diagnosis of primary progressive multiple sclerosis. Journal of the neurological sciences, 206(2), 145-52.
    23. Bourne T, Waltz M, Casper TC, Kavak K, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Graves J, Greenberg B, Gorman M, Harris Y, Krupp L, Lotze T, Mar S, Ness J, Olsen C, Roalstad S, Rodriguez M, Rose J, Rubin J, Schreiner T, Tillema JM, Kahn I, Waldman A, Barcellos L, Waubant E, Weinstock-Guttman B, US Network of Pediatric MS Centers (2017). Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population. Journal of the neurological sciences, 375, 371-375. (Read full publication)
    24. Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski I (2019). Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial. JAMA, 321(2), 165-174. (Read full publication)
    25. Sapkota N, Shi X, Shah LM, Bisson EF, Rose JW, Jeong E (2017). Two-dimensional single-shot diffusion-weighted stimulated EPI with reduced FOV for ultrahigh-b radial diffusion-weighted imaging of spinal cord. Magnetic resonance in medicine, 77(6), 2167-2173. (Read full publication)
    26. Kappos L, Wiendle H, Selmaj K, Arnold DL, Havrdova E, Boyko A, Kaufman M, Rose JW, Greenberg S, Sweetser M, Riester K, O'Neill G, Elkins (2015). Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis. The New England journal of medicine, 373(15), 1418-28.
    27. Chitnis T, Ness J, Krupp L, Waubant E, Hunt T, Olsen CS, Rodriguez M, Lotze T, Gorman M, Benson L, Belman A, Weinstock-Guttman B, Aaen G, Graves J, Patterson M, Rose JW, Casper T (2016). Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology, 86(3), 245-52. (Read full publication)
    28. Graves J, Grandhe S, Weinfurtner K, Krupp L, Belman A, Chitnis T, Ness J, Weinstock-Guttman B, Gorman M, Patterson M, Rodriguez M, Lotze T, Aaen G, Mowry EM, Rose JW, Simmons T, Casper TC, James J, Waubant E, US Network of Pediatric Multiple Sclerosis Centers (2014). Protective environmental factors for neuromyelitis optica. Neurology, 83(21), 1923-9. (Read full publication)
    29. Krysko KM, Graves J, Rensel M, Weinstock-Guttman B, Aaen G, Benson L, Chitnis T, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Rodriguez M, Rose J, Waltz M, Charles Casper T, Waubant E, US Network of Pediatric MS Centers (2018). Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology, 91(19), e1778-e1787. (Read full publication)
    30. Gianfrancesco MA, Stridh P, Rhead B, Shao X, Xu E, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Bäärnhielm M, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Metayer C, Schaefer C, Barcellos LF, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2017). Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology, 88(17), 1623-1629. (Read full publication)
    31. Santoro JD, Waltz M, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rensel M, Rodriguez M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Hurtubise BF, Roalstad S, Rose J, Casper TC, Chitnis T, US Network of Pediatric MS Centers (2020). Pediatric Multiple Sclerosis Severity Score in a large US cohort. Neurology, 95(13), e1844-e1853. (Read full publication)
    32. Burt RK, Balabanov R, Han X, Quigley K, Arnautovic I, Helenowski I, Rose J, Siddique (2021). Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder: A Clinical Trial. Neurology, 96(6), e817-e830. (Read full publication)
    33. Belman AL, Krupp LB, Olsen CS, Rose JW, Aaen G, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze T, Ness J, Rodriguez M, Tillema JM, Waubant E, Weinstock-Guttman B, Casper TC, US Network of Pediatric MS Centers (2016). Characteristics of Children and Adolescents With Multiple Sclerosis. Pediatrics, 138(1), (Read full publication)
    34. Charvet LE, Cleary RE, Vazquez K, Belman AL, Krupp L (2014). Social cognition in pediatric-onset multiple sclerosis (MS). Multiple sclerosis (Houndmills, Basingstoke, England), 20(11), 1478-84. (Read full publication)
    35. Ford C, Goodman AD, Johnson K, Kachuck N, Lindsey JW, Lisak R, Luzzio C, Myers L, Panitch H, Preiningerova J, Pruitt A, Rose J, Rus H, Wolinski (2010). Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate. Multiple sclerosis (Houndmills, Basingstoke, England), Mar(3), 342-50.
    36. Graves J, Barcellos LF, Shao X, Noble J, Mowry EM, Quach H, Belman A, Casper TC, Krupp LB, Waubant (2016). The US Network of Pediatric Multiple Sclerosis Centers: Genetic predictors of relapse rate in pediatric MS. Multiple sclerosis (Houndmills, Basingstoke, England), 1-8.
    37. Charvet LE, O'Donnell EH, Belman AL, Chitnis T, Ness JM, et al (2014). Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the "US Pediatric Multiple Sclerosis Network". Multiple sclerosis (Houndmills, Basingstoke, England), 20(11), 1502-10.
    38. Mehta LR, Rose J (2009). Recurrent granuloma annulare during treatment with daclizumab. Multiple sclerosis (Houndmills, Basingstoke, England), 15(4), 527-8.
    39. Wallach AI, Waltz M, Casper TC, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze TE, Mar S, Moodley M, Ness JM, Rensel M, Rodriguez M, Rose JW, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Charvet LE, Krupp L (2019). Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline. Multiple sclerosis (Houndmills, Basingstoke, England), 26(14), 1938-1947. (Read full publication)
    40. Graves JS, Barcellos LF, Krupp L, Belman A, Shao X, Quach H, Hart J, Chitnis T, Weinstock-Guttman B, Aaen G, Benson L, Gorman M, Greenberg B, Lotze T, Soe M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Casper TC, Waubant (2019). Vitamin D genes influence MS relapses in children. Multiple sclerosis (Houndmills, Basingstoke, England), 26(8), 894-901. (Read full publication)
    41. Cohan S, Kappos L, Giovannoni G, Wiendl H, Selmaj K, Havrdová EK, Rose J, Greenberg S, Phillips G, Ma W, Wang P, Lima G, Sabatella (2018). Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE. Multiple sclerosis (Houndmills, Basingstoke, England), 24(14), 1883-1891. (Read full publication)
    42. Gianfrancesco MA, Stridh P, Shao X, Rhead B, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Schaefer C, Barcellos LF, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2018). Genetic risk factors for pediatric-onset multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 24(14), 1825-1834. (Read full publication)
    43. Pakpoor J, Seminatore B, Graves JS, Schreiner T, Waldman AT, Lotze TE, Belman A, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, McDonald JC, Hart J, Ness JM, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Kahn I, Rose J, Carmichael SL, Roalstad S, Waltz M, Casper TC, Waubant E, US Network of Pediatric Multiple Sclerosis Centers (2018). Dietary factors and pediatric multiple sclerosis: A case-control study. Multiple sclerosis (Houndmills, Basingstoke, England), 24(8), 1067-1076. (Read full publication)
    44. Sapkota N, Yoon S, Thapa B, Lee Y, Bisson EF, Bowman BM, Miller SC, Shah LM, Rose JW, Jeong E (2016). Characterization of spinal cord white matter by suppressing signal from hindered space. A Monte Carlo simulation and an ex vivo ultrahigh-b diffusion-weighted imaging study. Journal of magnetic resonance (San Diego, Calif., 272, 53-59. (Read full publication)
    45. Rose JW, Foley JF, Carlson N (2009). Monoclonal antibody treatments for multiple sclerosis. Current treatment options in neurology, 11(3), 211-20. (Read full publication)
    46. Wynn D, Kaufman M, Montalban X, Vollmer T, Simon J, Elkins J, O'Neill G, Neyer L, Sheridan J, Wang C, Fong A, Rose JW, CHOICE investigators (2010). Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. The Lancet. Neurology, 9(4), 381-90. (Read full publication)
    47. Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Oyama Y, Russell EJ, Stern J, Muraro P, Rose JW, Testori A, Bucha J, Jovanovic B, Milanetti F, Storek J, Volterelli JC, Burns W (2009). Autologous non-myeloablative heamtopoetic stem cell transplantation for relapsing and remitting multiple sclerosis. The Lancet. Neurology, 8, 244-53.
    48. Carlson NG, Rojas MA, Black JD, Redd JW, Hille J, Hill KE, Rose J (2009). Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor. Journal of neuroinflammation, 6, 5. (Read full publication)
    49. Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee J (2009). Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. Journal of neuroinflammation, 6, 31. (Read full publication)
    50. Carlson NG, Rojas MA, Redd JW, Tang P, Wood B, Hill KE, Rose J (2010). Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death. Journal of neuroinflammation, 7, 25. (Read full publication)
    51. Carlson NG, Bellamkonda S, Schmidt L, Redd J, Huecksteadt T, Weber LM, Davis E, Wood B, Maruyama T, Rose J (2015). The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to death. Journal of neuroinflammation, 12, 101. (Read full publication)
    52. Minalga E, Rose JW, Choi SE, Jeong EK, Kholmovski E, et a (2011). A 20-channel coil for improved magnetic resonance imaging of the optic nerve. Concepts in magnetic resonance. Part B, Magnetic resonance engineering, 25(39B(1)), 26-36.
    53. Chi C, Shao X, Rhead B, Gonzales E, Smith JB, Xiang AH, Graves J, Waldman A, Lotze T, Schreiner T, Weinstock-Guttman B, Aaen G, Tillema JM, Ness J, Candee M, Krupp L, Gorman M, Benson L, Chitnis T, Mar S, Belman A, Casper TC, Rose J, Moodley M, Rensel M, Rodriguez M, Greenberg B, Kahn L, Rubin J, Schaefer C, Waubant E, Langer-Gould A, Barcellos L (2019). Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. PLoS genetics, 15(1), e1007808. (Read full publication)
    54. Baldassari LE, Rose J (2017). Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis. Neurotherapeutics, 14(4), 842-858. (Read full publication)
    55. Carlson NG, Rose J (2013). Vitamin D as a clinical biomarker in multiple sclerosis. Expert opinion on medical diagnostics, 7(3), 231-42.
    56. Rose JW, Carlson N (2011). Clinical biomarkers in multiple sclerosis. Expert opinion on medical diagnostics, 5(3), 213-26. (Read full publication)
    57. Fjeldstad AS, Carlson NG, Rose J (2012). Optical coherence tomography as a biomarker in multiple sclerosis. Expert opinion on medical diagnostics, 6(6), 593-604. (Read full publication)
    58. Sheridan JP, Robinson RR, Rose J (2014). Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosis. Expert review of clinical pharmacology, 7(1), 9-19.
    59. Rojas MA, Carlson NG, Miller TL, Rose J (2009). Long-term daclizumab therapy in relapsing-remitting multiple sclerosis. Therapeutic advances in neurological disorders, 2(5), 291-7. (Read full publication)
    60. Merrill RP, Hadley JR, Minalga E, Kholmovski EG, Vijayakumar S, Kim SE, Quigley EP, Parker DL, Rose J (2012). A 28-channel coil array for improved imaging of the optic nerve. Science translational medicine, 41B(3), 73-84.
    61. Rose J (2012). Anti-CD25 immunotherapy: regulating the regulators. Science translational medicine, 4(145), 145fs25. (Read full publication)
    62. Yonnet GJ, Fjeldstad AS, Carlson NG, Rose J (2013). Advances in the management of neurogenic detrusor overactivity in multiple sclerosis. International journal of MS care, 15(2), 66-72. (Read full publication)
    63. McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema J, Rodriquez M, Chitnis T, Mar S, Barcellos L, Laraia B, Rose JW, Roalstad S, Simmons T, Casper TC, Waubant (2016). A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Multiple sclerosis and related disorders, 6(Mar 2016), 87-92.
    64. Rose JW, Giovannoni G, Wiendl H, Gold R, Havrdová E, Kappos L, Selmaj KW, Zhao J, Riester K, Tsao LC, Greenberg S (2017). Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis. Multiple sclerosis and related disorders, 17, 32-40. (Read full publication)
    65. Suleiman L, Waubant E, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Gorman M, Goyal M, Greenberg B, Harris Y, Hart J, Kahn I, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Nourbakhsh B, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Tillema JM, Waldman A, Weinstock-Guttman B, Casper TC, Waltz M, Graves JS, Network of Pediatric Multiple Sclerosis Centers (2018). Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. Multiple sclerosis and related disorders, 22, 103-107. (Read full publication)
    66. Lavery AM, Waldman AT, Charles Casper T, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waubant E, U.S. Network of Pediatric MS Centers (2017). Examining the contributions of environmental quality to pediatric multiple sclerosis. Multiple sclerosis and related disorders, 18, 164-169. (Read full publication)
    67. Chan A, Rose J, Alvarez E, Bar-Or A, Butzkueven H, Fox RJ, Gold R, Gudesblatt M, Haartsen J, Spelman T, Wright K, Ferraro D, Sola P, Hodgkinson S, Kalincik T, Lechner-Scott J, McGuigan C, Spach K, Chen C, Fam S, Wu F, Miller (2020). Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS. Neurology. Clinical practice, 10(6), 510-519. (Read full publication)
    68. Jeong K, Shah LM, Lee YJ, Thapa B, Sapkota N, Bisson E, Carlson NG, Jeong EK, Rose J (2021). High-b diffusivity of MS lesions in cervical spinal cord using ultrahigh-b DWI (UHb-DWI). NeuroImage. Clinical, 30, 102610. (Read full publication)
    69. Rhead B, Shao X, Graves JS, Chitnis T, Waldman AT, Lotze T, Schreiner T, Belman A, Krupp L, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee MS, Gorman M, Benson L, Mar S, Kahn I, Rose J, Casper TC, Quach H, Quach D, Schaefer C, Waubant E, Barcellos LF, US Network of Pediatric MS Centers (2019). miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. Annals of clinical and translational neurology, 6(6), 1053-1061. (Read full publication)
    70. Mar S, Liang S, Waltz M, Casper TC, Goyal M, Greenberg B, Weinstock-Guttman B, Rodriguez M, Aaen G, Belman A, Barcellos LF, Rose J, Gorman M, Benson L, Candee M, Chitnis T, Harris Y, Kahn I, Roalsted S, Hart J, Lotze T, Moodley M, Ness J, Rensel M, Rubin J, Schreiner T, Tillema JM, Waldman A, Krupp L, Graves JS, Waubant E, U.S. Network of Pediatric Multiple Sclerosis Centers (2018). Several household chemical exposures are associated with pediatric-onset multiple sclerosis. Annals of clinical and translational neurology, 5(12), 1513-1521. (Read full publication)
    71. Lavery AM, Waubant E, Casper TC, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Charvet L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waldman A (2018). Urban air quality and associations with pediatric multiple sclerosis. Annals of clinical and translational neurology, 5(10), 1146-1153. (Read full publication)
    72. Nourbakhsh B, Rutatangwa A, Waltz M, Rensel M, Moodley M, Graves J, Casper TC, Waldman A, Belman A, Greenberg B, Goyal M, Harris Y, Kahn I, Lotze T, Mar S, Schreiner T, Aaen G, Hart J, Ness J, Rubin J, Tillema JM, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Candee M, Weinstock-Guttman B, Shao X, Barcellos L, James J, Waubant E, US Network of Pediatric MS Centers (2018). Heterogeneity in association of remote herpesvirus infections and pediatric MS. Annals of clinical and translational neurology, 5(10), 1222-1228. (Read full publication)
    73. Chitnis T, Graves J, Weinstock-Guttman B, Belman A, Olsen C, Misra M, Aaen G, Benson L, Candee M, Gorman M, Greenberg B, Krupp L, Lotze T, Mar S, Ness J, Rose J, Rubin J, Schreiner T, Tillema J, Waldman A, Rodriguez M, Casper C, Waubant E, U.S. Network of Pediatric MS Centers (2016). Distinct effects of obesity and puberty on risk and age at onset of pediatric MS. Annals of clinical and translational neurology, 3(12), 897-907. (Read full publication)
    74. Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, Bennett JL, Johnson R, Barnes-Garcia M, Traboulsee AL, Carruthers RL, Lee LE, Schubert JJ, McMullen K, Kister I, Rimler Z, Reid A, Sicotte NL, Planchon SM, Cohen JA, Ivancic D, Sedlak JL, Sand IK, Repovic P, Amezcua L, Pruitt A, Amundson E, Chitnis T, Mullin DS, Klawiter EC, Russo AW, Riley CS, Onomichi KB, Levine L, Nelson KE, Nealon NM, Engel C, Kruse-Hoyer M, Marcille M, Tornes L, Rumpf A, Greer A, Kenneally Behne M, Rodriguez RR, Behne DW, Blackway DW, Coords B, Blaschke TF, Sheard J, Smith TJ, Behne JM, Yeaman MR, Guthy-Jackson Charitable Foundation International Clinical Consortium (GJCF'ICC) (2019). Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD. Neurology(R) neuroimmunology & neuroinflammation, 6(5), e583. (Read full publication)
    75. Katz Sand I, Fabian MT, Telford R, Kraus TA, Chehade M, Masilamani M, Moran T, Farrell C, Ebel S, Cook LJ, Rose J, Lublin F (2018). Open-label, add-on trial of cetirizine for neuromyelitis optica. Neurology(R) neuroimmunology & neuroinflammation, 5(2), e441. (Read full publication)
    76. Lord J, Paz Soldan MM, Galli J, Salzman KL, Kresser J, Bacharach R, DeWitt LD, Klein J, Rose J, Greenlee J, Clardy S (2020). Neurosarcoidosis: Longitudinal experience in a single-center, academic healthcare system. Neurology(R) neuroimmunology & neuroinflammation, 7(4), (Read full publication)
    77. Abbatemarco JR, Galli JR, Sweeney ML, Carlson NG, Samara VC, Davis H, Rodenbeck S, Wong KH, Paz Soldan MM, Greenlee JE, Rose JW, Delic A, Clardy S (2021). Modern Look at Transverse Myelitis and Inflammatory Myelopathy: Epidemiology of the National Veterans Health Administration Population. Neurology(R) neuroimmunology & neuroinflammation, 8(6), (Read full publication)
    78. Greenberg BM, Casper TC, Mar SS, Ness JM, Plumb P, Liang S, Goyal M, Weinstock-Guttman B, Rodriguez M, Aaen GS, Belman A, Barcellos LF, Rose JW, Gorman MP, Benson LA, Candee M, Chitnis T, Harris YC, Kahn IL, Roalstad S, Hart J, Lotze TE, Rensel M, Rubin JP, Schreiner TL, Tillema JM, Waldman AT, Krupp L, Graves J, Drake K, Waubant (2021). Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation, 8(5), (Read full publication)
    79. Loughran-Fjeldstad AS, Carlson NG, Husebye CD, Cook LJ, Rose J (2015). Retinal nerve fiber layer sector-specific compromise in relapsing and remitting multiple sclerosis. eNeurologicalSci, 1, 30-37. (Read full publication)
    80. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Lynch S, Waubant E, US Network of Pediatric MS Center (2016). Gut microbiota composition and relapse risk in pediatric MS: A pilot study. Apr 16(363), 153-157.
    81. Williams JP, Abbatemarco JR, Galli JJ, Rodenbeck SJ, Peterson LK, Haven TR, Street M, Rose JW, Greenlee JE, Soldan MMP, Clardy S (2021). Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay. Multiple sclerosis international, 2021, 8692328. (Read full publication)
    82. Ziaei A, Lavery AM, Shao XM, Adams C, Casper TC, Rose J, Candee M, Weinstock-Guttman B, Aaen G, Harris Y, Graves J, Benson L, Gorman M, Rensel M, Mar S, Lotze T, Greenberg B, Chitnis T, Hart J, Waldman AT, Barcellos LF, Waubant (2022). Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution. Multiple sclerosis (Houndmills, Basingstoke, England), 28(9), 13524585211069926. (Read full publication)
    83. Mandel LA, O'Donnell E, Canenguez K, Castro-Mendoza PB, Lotze T, Waubant E, Weinstock-Guttmann B, Chitnis T (2021). Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis. Enhancing Equity.,
    84. Schreiner T, Wilson-Murphy M, Mendelt-Tillema J, Waltz M, Codden R, Benson L, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Roalstad S, Rodriguez M, Rose J, Shukla N, Waubant E, Wheeler Y, Casper TC, Chitnis T (2023). Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Mult Scler. 2023 Apr;29(4-5):576-584. doi: 10.1177/13524585231151948. Epub 2023 Mar 23.PMID: 36960480,
    85. Malani Shukla N, Casper TC, Ness J, Wheeler Y, Chitnis T, Lotze T, Gorman M, Benson L, Weinstock-Guttmann B, Aaen G, Rodriguez M, Tillema JM, Krupp L, Schreiner T, Mar S, Goyal M, Rensel M, Abrams A, Rose J, Waltz M, Liu T, Manlius C, Waubant (2023). U.S. Network of Pediatric Multiple Sclerosis Centers. Pediatr Neurol. 2023 Aug;145:125-131. doi: 10.1016/j.pediatrneurol.2023.04.020. Epub 2023 Apr 28.PMID: 37348193,
    86. Horton MK, Shim JE, Wallace A, Graves JS, Aaen G, Greenberg B, Mar S, Wheeler Y, Weinstock-Guttman B, Waldman A, Schreiner T, Rodriguez M, Tillema JM, Chitnis T, Krupp L, Casper TC, Rensel M, Hart J, Quach HL, Quach DL, Schaefer C, Waubant E, Barcellos L (2023). Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis. Mult Scler. 2023 Apr;29(4-5):505-511. doi: 10.1177/13524585221150736. Epub 2023 Feb 8.PMID: 36755464,
    87. Schoeps VA, Zhou X, Horton MK, Zhu F, McCauley KE, Nasr Z, Virupakshaiah A, Gorman MP, Benson LA, Weinstock-Guttman B, Waldman A, Banwell BL, Bar-Or A, Marrie RA, van Domselaar G, O'Mahony J, Mirza AI, Bernstein CN, Yeh EA, Casper TC, Lynch SV, Tremlett H, Baranzini S, Waubant (2024). US Network of Pediatric MS Centers. Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onset. Ann Clin Transl Neurol. 2024 Jan;11(1):169-184. doi: 10.1002/acn3.51944. Epub 2023 Nov 13.PMID: 37955284,
    88. Gambrah-Lyles C, Varun Kannan 2, Tim Lotze 2, Aaron Abrams 3, Teri Schreiner 4, Moses Rodriguez 5, T Charles Casper 6, John W Rose 7, Mark P Gorman 8, Tanuja Chitnis 9, Sara Loud 10, Yolanda Wheeler 11, Soe Mar 12; US Network of Pediatric MS Center (2024). Assessing the Needs and perceptions in research participation pediatric onset multiple sclerosis; a multi-stakeholder survey. Pediatr Neurol. 2024 Feb:151:115 120. doi:10.1016/j.pediatrneurol.2023.11.019.Epub 2023 Dec 4. PMID: 38154238,
    89. Nasr Z, Virupakshaiah A, Schoeps VA, Cherbuin N, Casper TC, Waltz M, Hart J, Rodriguez M, Gorman MP, Benson LA, Chitnis T, Rensel M, Abrams A, Krupp L, Waldman AT, Lotze T, Aaen GS, Mar S, Schreiner T, Wheeler Y, Rose J, Shukla NM, Barcellos LF, Lucas R, Waubant (2024). Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors. Multiple sclerosis and related disorders, 82, 105351. (Read full publication)
    90. Pizzolato Umeton R, Waltz M, Aaen GS, Benson L, Gorman M, Goyal M, Graves JS, Harris Y, Krupp L, Lotze TE, Shukla NM, Mar S, Ness J, Rensel M, Schreiner T, Tillema JM, Roalstad S, Rodriguez M, Rose J, Waubant E, Weinstock-Guttman B, Casper C, Chitnis T, US Network of Pediatric MS Center (2023). Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder. Neurology, 100(9), e985-e994. (Read full publication)
    91. Gholizadeh S, Exuzides A, Lewis KE, Palmer C, Waltz M, Rose JW, Jolley AM, Behne JM, Behne MK, Blaschke TF, Smith TJ, Sinnott J, Cook LJ, Yeaman MR, Guthy-Jackson Charitable Foundation CIRCLES Study Grou (2023). Clinical and epidemiological correlates of treatment change in patients with NMOSD: insights from the CIRCLES cohort. Journal of neurology, 270(4), 2048-2058. (Read full publication)
    92. Hoshina Y, Wong KH, Galli J, Bacharach R, Klein J, Lebiedz-Odrobina D, Rose JW, Trump B, Hull C, Greenlee JE, Clardy S (2023). Neurologic involvement in seronegative primary Sjögren's syndrome with positive minor salivary gland biopsy: a single-center experience. Frontiers in neurology, 14, 1174116. (Read full publication)
    93. Nasr Z, Schoeps VA, Ziaei A, Virupakshaiah A, Adams C, Casper TC, Waltz M, Rose J, Rodriguez M, Tillema JM, Chitnis T, Graves JS, Benson L, Rensel M, Krupp L, Waldman AT, Weinstock-Guttman B, Lotze T, Greenberg B, Aaen G, Mar S, Schreiner T, Hart J, Simpson-Yap S, Mesaros C, Barcellos LF, Waubant (2023). Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures. Journal of neurology, neurosurgery, and psychiatry, 94(7), 518-525. (Read full publication)
    94. Mandel LA, O'Donnell E, Canenguez K, Castro-Mendoza PB, Lotze T, Waubant E, Weinstock-Guttmann B, Chitnis (2021). Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity. Journal of patient experience, 8, 23743735211039319. (Read full publication)
    95. Gaudioso C, Oo S, Mar S, Hendricks-Ferguson VL, Newland P, Varni J (2021). PedsQL Multiple Sclerosis Module Domain and Item Development: Qualitative Methods. Journal of child neurology, 36(10), 901-910. (Read full publication)
    96. Santoro JD, Kerr LM, Codden R, Casper TC, Greenberg BM, Waubant E, Kong SW, Mandl KD, Gorman M (2021). Increased Prevalence of Familial Autoimmune Disease in Children With Opsoclonus-Myoclonus Syndrome. Neurology(R) neuroimmunology & neuroinflammation, 8(6), (Read full publication)
    97. Graves JS, Chitnis T, Weinstock-Guttman B, Rubin J, Zelikovitch AS, Nourbakhsh B, Simmons T, Waltz M, Casper TC, Waubant E, Network of Pediatric Multiple Sclerosis Center (2017). Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis. Pediatrics, 139(4), (Read full publication)
    98. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Spencer CM, Lynch SV, Zamvil SS, Waubant E, US Network of Pediatric MS Center (2016). Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls. BMC neurology, 16(1), 182. (Read full publication)
    99. Graves JS, Barcellos LF, Shao X, Noble J, Mowry EM, Quach H, Belman A, Casper TC, Krupp LB, Waubant E, U.S. Network of Pediatric MS Center (2016). Genetic predictors of relapse rate in pediatric MS. Multiple sclerosis (Houndmills, Basingstoke, England), 22(12), 1528-1535. (Read full publication)
    100. Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttman B, Yeh A, Rodriguez M, Ness J, Gorman MP, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, Pelletier D, Erickson B, Bergsland N, Zivadinov R, U.S. Network of Pediatric MS Centers of Excellenc (2013). Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. BMC neurology, 13, 173. (Read full publication)
    101. Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E, Brown T, O'Donnell E, Parrish J, Preston T, Zaccariello M, Belman A, Chitnis T, Gorman M, Ness J, Patterson M, Rodriguez M, Waubant E, Weinstock-Guttman B, Yeh A, Krupp LB, Network of Pediatric MS Centers of Excellenc (2013). Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. Journal of child neurology, 28(1), 102-7. (Read full publication)
    102. Waldman AT, Gorman MP, Rensel MR, Austin TE, Hertz DP, Kuntz NL, Network of Pediatric Multiple Sclerosis Centers of Excellence of National Multiple Sclerosis Societ (2011). Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists. Journal of child neurology, 26(6), 675-82. (Read full publication)
    103. Yeh EA, Waubant E, Krupp LB, Ness J, Chitnis T, Kuntz N, Ramanathan M, Belman A, Chabas D, Gorman MP, Rodriguez M, Rinker JR 2nd, Weinstock-Guttman B, National Network of Pediatric MS Centers of Excellenc (2011). Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Archives of neurology, 68(4), 437-44. (Read full publication)
    104. Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Chabas D, Strober J, McDonald J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, Oksenberg JR, James JA, US Pediatric MS Networ (2011). Common viruses associated with lower pediatric multiple sclerosis risk. Neurology, 76(23), 1989-95. (Read full publication)
    105. Chabas D, Ness J, Belman A, Yeh EA, Kuntz N, Gorman MP, Strober JB, De Kouchkovsky I, McCulloch C, Chitnis T, Rodriguez M, Weinstock-Guttman B, Krupp LB, Waubant E, US Network of Pediatric MS Centers of Excellenc (2010). Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology, 74(5), 399-405. (Read full publication)

    Review

    1. Kuntz NL, Chabas D, Weinstock-Guttman B, Chitnis T, Yeh EA, Krupp L, Ness J, Rodriguez M, Waubant E, Network of US Pediatric Multiple Sclerosis Center (2010). Treatment of multiple sclerosis in children and adolescents. Expert opinion on pharmacotherapy, 11(4), 505-20. (Read full publication)
    2. Yeh EA, Chitnis T, Krupp L, Ness J, Chabas D, Kuntz N, Waubant E, US Network of Pediatric Multiple Sclerosis Centers of Excellenc (2009). Pediatric multiple sclerosis. Nature reviews. Neurology, 5(11), 621-31. (Read full publication)

    Book Chapter

    1. Jacobson S, Rose J, Flerlage M, Mingioli E, McFarlin D, McFarland (1986). Measles virus-specific human cytotoxic T cells generated in bulk cultures: Analysis of measles virus antigenic specificity.

    Book Review

    1. Rose J (1984). Neuroimmunology.

    Editorial

    1. Rose J (2009). Multiple sclerosis: evidence of maternal effects and an increasing incidence in women. Neurology, 73(8), 578-9. (Read full publication)
    2. Rose (2009). Multiple Sclerosis: Evidence of Maternal Effects and an Increasing Incidence in Women. Neurology, 73(8), 578-9.

    Abstract

    1. Tremlett H, Fadrosh D, Lynch S, Hart J, Gravas J, Lulu S, Aaen G, Belman A, Benson L, Casper C, Chitnis T, Gorman M, Krupp L, Lotze T, Ness J, Roalstac S, Rodriquez M, Rose JW, Tillema JM, Weinstock-Guttman B, Waubant (2015). Gut Microbiome in Early Pediatric Multiple Sclerosis: A Case-control Study. Neurology, 84(14 Supplement), P4.027.
    2. McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tilleman JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos L, Rose JW, Roalstad S, Simmons T, Casper TC, Waubant (2015). A Case-control Study of Dietary Salt Intake and Risk of Pediatric Multiple Sclerosis (MS). Washington D.C. Neurology, 84(14 Supplement), S38.003.
    3. Seminatore B, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos L, Rose JW, Roalstad S, Simmons T, Casper C, Waubant (2015). Fat, Fiber, and Pediatric MS. Neurology, 84(14 Supplement), S38.002.
    4. Selmaj K, Kappos L, Arnold D, Havrdova E, Boyko A, Kaufman M, Wiendl H, Rose JW, Greenberg S, Riester K, Sweetser M, Elkins (2015). Safety and Tolerability Results from the DECIDE Study: A Phase 3 Active-comparator Study of Daclizumab HYP in Relapsing-remitting Multiple Sclerosis. Neurology, 84(14 Supplement), P7.230.
    5. Paz Soldan M, Schmidt L, Wood B, Rose JW, Carlson (2015). Prostaglandin F2a Receptor Mediates Oligodendrocyte Precursor Injury/Death: Potential Rose in Multiple Sclerosis. Washington D.C. Neurology, 84(14 Supplement), P5.210.
    6. Rose JW, Wiendl H, Arnold D, Kappos L, Havrdova E, Selmaj K, Boyko A, Kaufman M, Greenberg S, Sweetser M, Riester K, Elkins (2015). Daclizumab HYP Reduced Brain MRI Lesion Activity Compared with Interferon Beta-1a: Results from the DECIDE Study. Neurology, 84(14 Supplement), P7.252.
    7. Wang V, Clardy T, Rose JW, Burns J, Carlson N, Greenlee J, Clardy (2015). Neuromyelitis Optica in Veterans. Neurology, 84(14 Supplement), P1.104.
    8. Kappos L, Selmaj K, Arnold D, Havrdova E, Boyko A, Kaufman M, Wiendl H, Rose JW, Greenberg S, Sweetser M, Riester K, Elkins (2015). Daclizumab HYP Versus Interferon Beta-1a in Relapsing-remitting Multiple Sclerosis: Primary Results of the DECIDE Study. Neurology, 84(14 Suppliment), S4.003.
    9. Sand IK, Fabian M, Cook L, Chehade M, Masilamani M, Kraus T, Farrell C, Phelps S, Riffle ME, Rose JW, Moran T, Lublin (2015). An Open Label Add-on Trial of Cetirizine for Neuromyelitis Optica. Neurology, 84(14 Supplement), P4.003.
    10. Wiendl H, Havrdova E, Rose JW, Riester K, Tsao C, Greenberg (2015). Daclizumab HYP Versus Interferon ß-1a Across Patient Demographic and Disease Activity Subgroups in the DECIDE Phase 3 Study. Neurology, 84(14 Supplement), P4.007.
    11. Rose JW, Jaskowski T, Husebye D, Seraj H, Hill H, Carlson (2008). Anti-thyroid antibodies identify a subgroup of multiple sclerosis patients.
    12. Mehta L, Rose J (2008). Recurrent granuloma annulare occurring during treatment with daclizumab.
    13. Hadley R, Merrill R, Minalga E, Parker D, Rose J (2008). Improved radio frequency coils for 3T magnetic resonance imaging of the optic nerve.
    14. Tsunoda I, Carlson N, Rose J (2008). Treatment with a red wine component, resveratrol, in a virus induced model for MS.
    15. Carlson N, Rojas M, Redd J, Wood B, Hill K, Rose J (2008). A COX-2 inhibitor limits demyelination in a murine model of MS and protects oligodendrocytes from excitotoxic death in culture.
    16. Jaskowski T, Husebye D, Yarden J, Spector L, Fire E, Dotan N, Hill H, Rose J (2008). Performance of an anti-GAGA4 IgM assay in distinguishing MS patients from control groups in a US cohort: a cross sectional retrospective study.
    17. Burt R, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Rose JW, Testori A, Muraro P, Storek J and Voltarelli (2008). Autologous non myeloablative hematopoetic stem cell transplantation for relapsing multiple sclerosis.
    18. Tsunoda I, Rose JW, Carlson (2008). Treatment on an animal model for MS with resveratrol, a red wine component.
    19. Carlson N, Rojas M, Redd J, Wood B, Hill K, Rose J (2008). The role of COX-2 in experimental oligodendrocytes death and demyelination.
    20. Carlson N, Rojas M, Black J-D, Redd J, Hill K, Rose J (2008). Neuroprotection by EP1 prostanoid receptor antagonists is modulated by microglia.
    21. Kim T, Kim SE, Patel A, Zollinger L, Rose JW, Jeong E (2009). Diffusion tensor imaging of human spinal cords in cervical myelopathy.
    22. Merrill R, Hadley R, Minalga E, Parker D, Vijayakumar S, Choi SEK, Bell L, Rose J (2009). An improved 28 channel array for optic nerve imaging.
    23. Carlson N, Rojas M, Redd J, Tang P, Wood B, Hill K, Rose J (2009). Cyclooxygenase-2 expression in oligodendrocytes increases sensitiity to excitotoxic death.
    24. Tumani H, Brettschneider J, Jakowski T, Abdul S, Husebye D, Seraj H, Hill H, Fire E, Spector L, Dotan N, Rose J (2009). Anti-GAGA4 IgM assay may distinguish primary progressive multiple sclerosis from relapsing remitting multiple sclerosis patients.
    25. Rose JW, Quigley E, Anderson J, Kim S, Jeong EK, Minalga E, Merrill R, Parker D, Hadley (2009). Imaging of the optic nerve with improved radiofrequency toils for 3T MRI.
    26. Nourbakhsh B, Graves J, Lulu S, Waldman A, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema J-M, Hart J, Lee M, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Simmons T, Casper C, Rose JW, Barcellos L, Waubant (2015). Association of dietary salt intake and relapse rate in pediatric multiple sclerosis.
    27. Chitnis T, Graves J, Weinstock-Guttman B, Belman A, Misra M, Olsen CS, Aaen G, Benson L, Candee M, Gorman M, Greenberg B, Lotze T, Ness J, Rodriquez M, Rose JW, Rubin J, Schreiner T, Mendelt-Tillema J, Casper TC, Waubant (2015). Effect of obesity and puberty on risk and age at onset of pediatric MS.
    28. Aaen GS, Waltz M, Casper T, Ness J, Gorman M, Makahani N, Vargas W, Waubant E, Chitnis T, Lotze T, Graves J, Benson L, Tillema MJ, Rodriguez M, Rose JW, Weinstock-Guttman B, Krupp L, Belman (2015). Acquisition of early developmental milestones and need for special education services in paediatric-onset multiple sclerosis.
    29. Loughran-Fjeldstad AS, Carlson NG, Cook LJ , Rose J (2015). Longitudinal reduction of total macular volume in relapsing and remitting multiple sclerosis: indicative of ongoing neurodegeneration.
    30. Wiendl H , Havrdova E, RoseJW, Giovannoni G, Tsao LC, Zhao J, Pan Q, Elkins J, Greenberg S (2015). Daclizumab high-yield process (DAC HYP) vs. intramuscular interferon beta-1a in subgroups predictive of active disease: results from the DECIDE study.
    31. Arnold DL, Kappos L, Wiendl H, Selmaj K, Havrdova E, Boyko A, Kaufman M, Rose JW, Greenberg S, Amaravadi L, Riestger K, Elkins (2015). Benefits on brain MRI lesion activity with Daclizumab HYP compared with intramuscular interferon beta- 1a are maintained through 144 weeks¿ treatment: results from the DECIDE study.
    32. Katz Sand I, Fabian M, Cook L, Telford R, Chehade M, Masilamani M, Kraus T, Farrell C, Phelps S, Riffle ME, Rose JW, Moran T, Lublin (2015). An open-label add-on trial of cetirizine for neuromyelitis optica: baseline data and preliminary results.
    33. Carlson NG, Schmidt L, Redd J, Bellamkonda S, Wood B, Weber LM, Paz Soldan MM, RoseJ (2015). Vulnerability of oligodendrocyte precursor cells to death is modulated by key prostaglandins.

    Other

    1. Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ, (J Rose, S Clardy and MM Paz Soldan in PREVENT Study Group) (2021). Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD. Annals of neurology, 89(6), 1088-1098. (Read full publication)
    2. Jeong KE, Lee SY, Yeom SK, Carlson N, Shah LM, Rose J, Jeong E (2022). Ultrahigh-b diffusion-weighted imaging for quantitative evaluation of myelination in shiverer mouse spinal cord. Magnetic resonance in medicine, 87(1), 179-192. (Read full publication)
    3. Sebastian P, Cherbuin N, Barcellos LF, Roalstad S, Casper C, Hart J, Aaen GS, Krupp L, Benson L, Gorman M, Candee M, Chitnis T, Goyal M, Greenberg B, Mar S, Rodriguez M, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Graves J, Waubant E, Lucas R, US Network of Pediatric Multiple Sclerosis Centers (2022). Association Between Time Spent Outdoors and Risk of Multiple Sclerosis. Neurology, 98(3), e267-e278. (Read full publication)
    4. Horton MK, McCauley K, Fadrosh D, Fujimura K, Graves J, Ness J, Wheeler Y, Gorman MP, Benson LA, Weinstock-Guttman B, Waldman A, Rodriguez M, Tillema JM, Krupp L, Belman A, Mar S, Rensel M, Chitnis T, Casper TC, Rose J, Hart J, Shao X, Tremlett H, Lynch SV, Barcellos LF, Waubant E, U.S. Network of Pediatric MS Centers (2021). Gut microbiome is associated with multiple sclerosis activity in children. Annals of clinical and translational neurology, 8(9), 1867-1883. (Read full publication)
    5. Vikram Bhise a, Michael Waltz b, Charles Casper b, Gregory Aaen c, Leslie Benson d, Tanuja Chitnis e, Mark Gorman f, Manu Goyal g, Yolanda Wheeler h, Timothy Lotze i, Soe Mar j, Mary Rensel k, Aaron Abrams l, Moses Rodriguez m, John Rose n, Teri Schreiner o, Nikita Shukla p, Emmanuelle Waubant q, Bianca Weinstock-Guttman r, Jayne Ness s, Jan Mendelt-Tillema (2023). Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort.